These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28707025)

  • 1. Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China.
    Meyers K; Wu Y; Qian H; Sandfort T; Huang X; Xu J; Zhang J; Xia W; Glidden D; Wu H; Shang H
    AIDS Behav; 2018 Apr; 22(4):1217-1227. PubMed ID: 28707025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
    Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
    PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.
    Parsons JT; Rendina HJ; Whitfield TH; Grov C
    AIDS Behav; 2016 Jul; 20(7):1390-9. PubMed ID: 27000145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
    John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
    AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia.
    Paudel K; Gupta S; Gautam K; Wickersham JA; Khati A; Azwa I; Ha T; Shrestha R
    J Community Health; 2023 Jun; 48(3):513-521. PubMed ID: 36732459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
    Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
    BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.
    Fu J; Dai Z; Wang H; Si M; Chen X; Wu Y; Xiao W; Huang Y; Yu F; Mi G; Su X
    PLoS One; 2023; 18(10):e0293297. PubMed ID: 37856527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.
    Levy ME; Patrick R; Gamble J; Rawls A; Opoku J; Magnus M; Kharfen M; Greenberg AE; Kuo I
    PLoS One; 2017; 12(8):e0183521. PubMed ID: 28827821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach.
    Wang H; Zimmermann HML; van de Vijver D; Jonas KJ
    AIDS Care; 2024 Jul; 36(sup1):89-100. PubMed ID: 38713631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
    Marshall BDL; Goedel WC; King MRF; Singleton A; Durham DP; Chan PA; Townsend JP; Galvani AP
    Lancet HIV; 2018 Sep; 5(9):e498-e505. PubMed ID: 29908917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).
    Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B;
    Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.
    Mansergh G; Kota KK; Stephenson R; Hirshfield S; Sullivan P
    J Int AIDS Soc; 2021 Jan; 24(1):e25664. PubMed ID: 33481359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study.
    Reyniers T; Fiorentino M; Babo SAY; Ouedraogo M; Kanta I; Agbegnigan LE; Rojas D; Anoma C; Dah TTE; Mensah E; Keita BD; Spire B; Vuylsteke B; Laurent C
    AIDS Patient Care STDS; 2023 Oct; 37(10):480-488. PubMed ID: 37862074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
    Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
    BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of Injectable and On-Demand Pre-Exposure Prophylaxis Among an Online Sample of Young Men Who Have Sex with Men in California.
    Beymer MR; Gildner JL; Holloway IW; Landovitz RJ
    LGBT Health; 2018; 5(6):341-349. PubMed ID: 30118399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
    Ellison J; van den Berg JJ; Montgomery MC; Tao J; Pashankar R; Mimiaga MJ; Chan PA
    AIDS Patient Care STDS; 2019 Nov; 33(11):482-491. PubMed ID: 31603712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Determinants and Implementation Strategies to Increase Long-Acting Injectable PrEP for HIV Prevention Among Latino Men Who Have Sex with Men (MSM).
    Zapata JP; Zamantakis A; Queiroz AAFLN
    J Racial Ethn Health Disparities; 2024 Aug; 11(4):2093-2102. PubMed ID: 37347407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men.
    Greene GJ; Swann G; Fought AJ; Carballo-Diéguez A; Hope TJ; Kiser PF; Mustanski B; D'Aquila RT
    AIDS Behav; 2017 May; 21(5):1336-1349. PubMed ID: 27770215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication.
    Biello KB; Mimiaga MJ; Santostefano CM; Novak DS; Mayer KH
    AIDS Behav; 2018 Apr; 22(4):1158-1164. PubMed ID: 29119472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.